Welcome to the e-CCO Library!

P138: Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. W. M. Pauwels*1, C. J. van der Woude1, D. Nieboer2, E. W. Steyerberg2,3, M. J. Casanova4, J. P. Gisbert4, A. J. Lobo5, C. W. Lees6, N. A. Kennedy5, T. Molnár7, K. Szánto7, E. Louis8, J-Y. Mary9, M. Lukas10,11, M. Duijvestein12, S. Bots12, G. R. A. M. D'Haens12, A. C. de Vries1

Created: Friday, 22 February 2019, 9:41 AM
P138: Psychometric validation and interpretation of a patient-reported outcomes instrument to assess bowel urgency among adults with moderate to severe Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Dubinsky, M.C.(1);Delbecque, L.(2);Lewis, J.(3);Hunter, T.(4);Shan, M.(5);
Created: Friday, 11 February 2022, 3:52 PM
P138: Results of dysplasia surveillance programme with chromoendoscopy for inflammatory bowel disease: do we have to biopsy all lesions?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. F. Muñoz*1, M. García-Alvarado2, B. Sicilia3, M. Sierra4, N. Fernandez4, L. Arias3, J. Barrio5, B. Velayos6, L. Hernández-Villalba7

Created: Friday, 22 February 2019, 9:49 AM
P138: The use of video capsule endoscopy (vce) in patinets with a new diagnosis of Crohn's disease: the experience of one center
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Nicolaou, P.(1)*;Theodoropoulou, A.(1);Psistakis, A.(1);Arna, D.(1);Velegraki, M.(1);Fragkaki, M.(1);Karmiris, K.(1);Vardas, E.(1);Paspatis, G.(1);
Created: Friday, 14 July 2023, 10:48 AM
P139 Prevalence of infections in patients affected by inflammatory bowel disease treated with anti-TNF-α agents: a single-centre experience
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Imperatore1, M. Foggia2, A. Rispo1, M. Patturelli1, G. Calabrese2, A. Testa1, O. Nardone1, L. Pellegrini1, A.D. Guarino1, S. Ricciolino1, G. Tosone2, F. Castiglione1

Created: Thursday, 30 January 2020, 10:12 AM
P139: Advance of medical therapies may improve outcome of ulcerative colitis with cytomegalovirus infection
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Kitamoto*1, S. Yamamoto1, M. Matsuura1, Y. Honzawa1, S. Yamada1, M. Okabe1, H. Seno1

Created: Friday, 22 February 2019, 9:41 AM
P139: Articular manifestations in inflammatory bowel disease – results from Northeastern Romania
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cardoneanu A.*1, Rezus E.1, Gavrilescu O.2, Cijevschi-Prelipcean C.2, Dranga M.2, Badescu A.3, Drug V.2, Stanciu C.2, Trifan A.2, Mihai C.2

Created: Wednesday, 20 February 2019, 10:36 AM
P139: Body composition and Crohn’s disease behavior: Is adiposity the main game changer?
Year: 2022
Source: ECCO'22
Authors: Morão, B.(1);Velho, S.(2);Agostinho, L.(3);Torres, J.(1);Cravo, M.(4);
Created: Friday, 11 February 2022, 3:52 PM
P139: Diagnostic potential of thermography in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Bozin1*, D. Kolaric2, M. Lucijanic3, S. Antonini4, T. Kulis5, M. Crncevic-Urek1, L. Prka1, M. Banic1

Created: Thursday, 21 February 2019, 9:14 AM
P139: Gut bacterial DNA translocation is an independent risk factor of flare in the short term in patients with Crohn’s disease (ADATHEC study)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Juanola1, 2, A. Gutiérrez3, P. Zapater1, L. Sempere3, M. García4, R. Laveda5, A. Martínez5, M. Scharl6, J. M. González-Navajas1, P. Piñero1, R. Wiest7, R. Francés*1, 2

Created: Friday, 22 February 2019, 9:49 AM
P139: Inflammatory bowel disease and impairment of working life
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mtir, M.(1)*;Kchir, H.(1);Mechergui, N.(2);Cherif, D.(1);Debbabi, H.(1);Yacoub, H.(1);Hassine, H.(1);Maamouri, N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P139: Significant Changes In Routine Biochemical Markers Occur Up To 5 Years Prior To Inflammatory Bowel Disease Diagnosis: A Case-Control Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Cohen, N.A.(1,2,3);Kliper, E.(4);Zamstein, N.(5);Ziv-Baran, T.(6);Ben Tov, A.(2,3);Kariv, R.(1,2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P140 Factors associated with development of NAFLD in patients with inflammatory bowel disease: a 5-year retrospective study on 225 patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Domislović1, I. Knežević-Štromar1,2, M. Premužić1, M. Brinar1,3, D. Vranešić Bender4, A. Milinković3, M. Matašin3, I. Mikolašević5,6, Ž. Krznarić1,2,4

Created: Thursday, 30 January 2020, 10:12 AM
P140: Biopsies taken from mucosa surrounding dysplastic lesions found during IBD surveillance show a low rate of dysplasia
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Ten Hove*1, E. Mooiweer1, A. Van der Meulen2, E. Dekker3, J. Offerhaus1, C. Ponsioen3, B. Oldenburg1

Created: Friday, 22 February 2019, 9:49 AM
P140: Challenges in colonoscopic surveillance in chronic IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S-L. Gillespie*1, N. Singh-Clark2, A. Shand1, C. Lees1, I. Arnott1, G-T. Ho1, E. Watson1, C. Noble1, S. Din1

Created: Friday, 22 February 2019, 9:41 AM
P140: Costs of home-monitoring by telemedicine versus standard care management of Inflammatory Bowel Disease – a Danish register-based five-year follow-up study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Al-Sheikh, M.(1)*;Olsen, J.(2);Spangaard, M.(2);Egedesø, P.(2);Peters-Lehm, C.(1);Fjordside, E.(1);Bennedsen, M.(1);Burisch, J.(1);Munkholm, P.(1);
Created: Friday, 14 July 2023, 10:48 AM
P140: Immunomodulators are protective against severe COVID 19: results from a large multicentre cohort of inflammatory bowel disease patients
Year: 2022
Source: ECCO'22
Authors: Vuitton, L.(1);Bourrier, A.(2);Uzzan, M.(3);Nachury, M.(4);Amiot, A.(5);Roblin, X.(6);Allez, M.(7);Altwegg, R.(8);Vidon, M.(9);Bourreille, A.(10);Serrero, M.(11);Pelletier, A.L.(12);Filippi, J.(13);Gilletta, C.(14);Simon, M.(15);Laharie, D.(16);Nahon, S.(17);Duveau, N.(18);Biron, A.(19);Viennot, S.(20);Abitbol, V.(21);Elgharabawy, Y.(22);Peyrin-Biroulet, L.(23);
Created: Friday, 11 February 2022, 3:52 PM
P140: Physician attitudes about the use of immunosuppressive therapy for inflammatory bowel disease in the elderly
Year: 2018
Source: ECCO '18 Vienna
Authors:

W.P.W. Chan1,2, S. Kim1, J.N. Ding3, V. Kariyawasam1, R.W. Leong1*

Created: Thursday, 21 February 2019, 9:14 AM
P140: Predicting Non-Responsiveness to Iron Therapy in Anaemic Children with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Bevers , N.(1);Aliu , A.(1);Rezazadeh Ardabili , A.(2);Winkens , B.(3);Raijkmakers , M.(4);van de Vijver , E.(5);Swinkels , D.(6);Pierik , M.(2);van Rheenen , P.(7);
Created: Wednesday, 2 June 2021, 4:12 PM
P140: Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Daffra P.R.*1, Etchevers M.J.1, Sobrero M.J.1, Gonzalez Sueyro R.C.1, Rainero G.2, Carbonnel F.3, Vaysse T.3, Marcolongo M.M.1, De Paula J.A.1

Created: Wednesday, 20 February 2019, 10:36 AM